Overview

Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke

Status:
Terminated

Trial end date:
2015-04-01

Target enrollment:

Participant gender:

Summary

This is a randomized, placebo-controlled, phase 3 clinical trial to evaluate the efficacy and safety of transcranial ultrasound (US) as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke.

Phase:

Phase 3

Details

Lead Sponsor:

Cerevast Therapeutics, Inc.

Treatments:

Plasminogen
Tissue Plasminogen Activator